2026-2030年全球神经调控市场

全球神经调控市场预计在2025年至2030年间成长至88.555亿美元，预测期内复合年增长率（CAGR）为14.0%。本报告对全球神经调控市场进行了全面分析，包括市场规模和预测、趋势、成长要素和挑战，以及对约25家公司的供应商分析。

本报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析。市场成长的驱动因素包括慢性疼痛和神经系统疾病盛行率的上升、全球人口老化带来的神经调控需求成长，以及新兴市场因医疗基础设施改善而扩张。

本研究采用客观的方法，结合一手和二手讯息，包括来自主要行业相关人员的意见。报告包含全面的市场规模数据、区域細項分析、供应商格局以及对主要企业的分析。报告提供历史数据和预测数据。

研究指出，非侵入式穿戴装置能够实现居家治疗，是未来几年推动全球神经调控市场成长的关键因素之一。此外，整合数位疗法以提高患者依从性和后续观察效果，以及小型化、兼容核磁共振植入以提升患者舒适度，预计也将显着刺激市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 价格、生命週期、顾客购买篮、采用率和购买标准分析
• 投入与差异化因素的重要性
• 混淆来源
• 驱动因素和挑战的影响

第三章 市场情势

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场定义
• 市场区隔分析
• 2025年市场规模
• 2025-2030年市场展望

第五章 市场规模表现

• 2020-2024年全球神经调控市场
• 2020-2024年产品细分市场分析
• 2020-2024年最终用户细分市场分析
• 应用细分市场分析 2020-2024
• 2020-2024年区域市场分析
• 2020-2024年国家细分市场分析

第六章 定性分析

• 人工智慧对全球神经调控市场的影响

第七章五力分析

• 五力分析概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第八章 按产品进行市场细分

• 比较：按产品
• 植入式神经调控装置
• 体外神经调控装置
• 按产品分類的市场机会

9. 按最终用户分類的市场细分

• 比较：按最终用户
• 医院
• 门诊手术中心（ASC）
• 其他的
• 按最终用户分類的市场机会

第十章 按应用程式进行市场细分

• 比较：按应用
• 癫痫
• 肥胖
• 忧郁症
• 缺血
• 按应用分類的市场机会

第十一章 客户情况

第十二章 区域情势

• 区域细分
• 区域比较
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 荷兰
• 亚洲
  • 中国
  • 日本
  • 印度
  • 韩国
  • 印尼
  • 泰国
• 世界其他地区
  • 巴西
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 土耳其
  • 阿根廷
  • 哥伦比亚
  • 南非
  • 以色列
• 各区域的市场机会

第十三章：驱动因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 令人困惑的局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 企业排名指数
• 公司市场定位
• Abbott Laboratories
• Boston Scientific Corp.
• BrainsWay Ltd.
• Cognito Therapeutics Inc.
• electroCore Inc.
• Flow Neuroscience AB
• INSIGHTEC Ltd.
• LivaNova PLC
• Medtronic Plc
• Neuronetics Inc.
• NeuroPace Inc.
• NeuroSigma Inc.
• Nevro Corp.
• Saluda Medical Pty Ltd.
• Theranica Bio Electronics Ltd.

第十六章附录

The global neuromodulation market is forecasted to grow by USD 8855.5 mn during 2025-2030, accelerating at a CAGR of 14.0% during the forecast period. The report on the global neuromodulation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic pain and neurological disorders, global aging population fueling neuromodulation demand, emerging markets expanding due to healthcare infrastructure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global neuromodulation market is segmented as below:

By Product

• Implantable neuromodulation devices
• External neuromodulation devices

By End-User

• Hospitals
• ASCs
• Others

By Application

• Epilepsy
• Obesity
• Depression
• Ischemia

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the non-invasive and wearable devices enabling home therapy as one of the prime reasons driving the global neuromodulation market growth during the next few years. Also, digital therapeutics integration improving adherence and tracking and miniaturized mri-safe implants enhancing patient comfort will lead to sizable demand in the market.

The report on the global neuromodulation market covers the following areas:

• Global neuromodulation market sizing
• Global neuromodulation market forecast
• Global neuromodulation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global neuromodulation market vendors that include Abbott Laboratories, BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., Cognito Therapeutics Inc., electroCore Inc., Flow Neuroscience AB, INSIGHTEC Ltd., LivaNova PLC, Medtronic Plc, Neuroelectrics Barcelona SLU, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., Nevro Corp., Saluda Medical Pty Ltd., Synapse Biomedical Inc., Theranica Bio Electronics Ltd.. Also, the global neuromodulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Neuromodulation Market 2020 - 2024
  • Historic Market Size - Data Table on Global Neuromodulation Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 The Impact of AI on Global Neuromodulation Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Implantable neuromodulation devices - Market size and forecast 2025-2030
• 8.4 External neuromodulation devices - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 ASCs - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Epilepsy - Market size and forecast 2025-2030
• 10.4 Obesity - Market size and forecast 2025-2030
• 10.5 Depression - Market size and forecast 2025-2030
• 10.6 Ischemia - Market size and forecast 2025-2030
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 France - Market size and forecast 2025-2030
  • 12.4.3 UK - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic pain and neurological disorders
  • Global aging population fueling neuromodulation demand
  • Emerging markets expanding due to healthcare infrastructure
• 13.2 Market challenges
  • High device and procedure costs limiting accessibility
  • Stringent regulatory approvals delaying market entry
  • Supply-chain inefficiencies increasing delays and costs
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Non-invasive and wearable devices enabling home therapy
  • Digital therapeutics integration improving adherence and tracking
  • Miniaturized MRI-safe implants enhancing patient comfort

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key news
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 15.6 BrainsWay Ltd.
  • BrainsWay Ltd. - Overview
  • BrainsWay Ltd. - Product / Service
  • BrainsWay Ltd. - Key offerings
  • SWOT
• 15.7 Cognito Therapeutics Inc.
  • Cognito Therapeutics Inc. - Overview
  • Cognito Therapeutics Inc. - Product / Service
  • Cognito Therapeutics Inc. - Key offerings
  • SWOT
• 15.8 electroCore Inc.
  • electroCore Inc. - Overview
  • electroCore Inc. - Product / Service
  • electroCore Inc. - Key offerings
  • SWOT
• 15.9 Flow Neuroscience AB
  • Flow Neuroscience AB - Overview
  • Flow Neuroscience AB - Product / Service
  • Flow Neuroscience AB - Key offerings
  • SWOT
• 15.10 INSIGHTEC Ltd.
  • INSIGHTEC Ltd. - Overview
  • INSIGHTEC Ltd. - Product / Service
  • INSIGHTEC Ltd. - Key offerings
  • SWOT
• 15.11 LivaNova PLC
  • LivaNova PLC - Overview
  • LivaNova PLC - Business segments
  • LivaNova PLC - Key news
  • LivaNova PLC - Key offerings
  • LivaNova PLC - Segment focus
  • SWOT
• 15.12 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.13 Neuronetics Inc.
  • Neuronetics Inc. - Overview
  • Neuronetics Inc. - Product / Service
  • Neuronetics Inc. - Key offerings
  • SWOT
• 15.14 NeuroPace Inc.
  • NeuroPace Inc. - Overview
  • NeuroPace Inc. - Product / Service
  • NeuroPace Inc. - Key offerings
  • SWOT
• 15.15 NeuroSigma Inc.
  • NeuroSigma Inc. - Overview
  • NeuroSigma Inc. - Product / Service
  • NeuroSigma Inc. - Key offerings
  • SWOT
• 15.16 Nevro Corp.
  • Nevro Corp. - Overview
  • Nevro Corp. - Product / Service
  • Nevro Corp. - Key offerings
  • SWOT
• 15.17 Saluda Medical Pty Ltd.
  • Saluda Medical Pty Ltd. - Overview
  • Saluda Medical Pty Ltd. - Product / Service
  • Saluda Medical Pty Ltd. - Key offerings
  • SWOT
• 15.18 Theranica Bio Electronics Ltd.
  • Theranica Bio Electronics Ltd. - Overview
  • Theranica Bio Electronics Ltd. - Product / Service
  • Theranica Bio Electronics Ltd. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations